Hilleman Laboratories Pvt
Business Services · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Extension New D-15 Ground Florida, Jungp...Phone Number
+91 1130997700Website
www.hilleman-labs.orgRevenue
$6.5 MillionIndustry
About Hilleman Laboratories Pvt
Hilleman Laboratories Pvt Org Chart
Is Hilleman Laboratories Pvt your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Hilleman Laboratories Pvt had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Hilleman Laboratories Pvt has new funding data
Product Launch: Get notified when Hilleman Laboratories Pvt launches new products
Check if Hilleman Laboratories Pvt has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Hilleman Laboratories Pvt
Check out if Hilleman Laboratories Pvt is spiking on competitors!
Earning: See what the market has to say on Hilleman Laboratories Pvt recently announced quarterly report
Hilleman Laboratories Pvt, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Hilleman Laboratories Pvt is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hilleman Laboratories Pvt is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hilleman Laboratories Pvt.
Hilleman Laboratories Pvt Tech Stack
A closer look at the technologies used by Hilleman Laboratories Pvt
Most Recent Scoops
Hilleman Laboratories Pvt News & Media
Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy
SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Teijin Limited and Hilleman Laboratories, a biotechnology company based in Singapore, announced today the signing of a Memorandum of Understanding, for the establishment of a strategic international business partnership. The goal of this partnership is to promote the expansion in contract development and manufacturing organization (CDMO) business in the field of cell and gene therapy. Memorandum of Understanding signing ceremony by Dr. Raman Rao (CEO, HilUnique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market
Singapore-based Hilleman Laboratories, along with Bharat Biotech, confirm launch of new cholera vaccine, HILLCHOL® Success provides "template for the internationalization of future vaccine and biologics development from Singapore" – Dr. Raman Rao, CEO, Hilleman Laboratories Hilleman...Hilleman Laboratories unveils $20 million Singapore facility to boost vaccine manufacturing
Hilleman Laboratories has opened a new 30,000 sq ft manufacturing facility in Singapore.SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation Zaire Ebola Virus Vaccine
SK bioscience will partner with Hilleman Laboratories Singapore to develop a low-cost, improved manufacturing process of MSD's second-generation Ebola-Zaire vaccine. SEONGNAM, South Korea, Nov. 22, 2023 /PRNewswire/ -- SK bioscience, an innovative vaccine and biotech company committed to...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hilleman Laboratories Pvt
Hilleman Laboratories is a medical research organization dedicated to developing high-impact, affordable vaccines for people in developing countries. With a focus on innovative and sustainable practices, the organization aims to overcome barriers to vaccine access for millions. Based in Singapore, Hilleman Laboratories translates early vaccine disc... Read More